Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03217461Not ApplicableCompleted

Corneal Autograft for Limbal Dermoid

Role: lead

NCT03217435Not ApplicableCompleted

Corneal Epithelial Allograft From Living-related Donor for LSCD

Role: lead

NCT03217487Not ApplicableUnknown

Corneal Epithelial Autograft for LSCD

Role: lead

NCT03217500Not ApplicableUnknown

Corneal Epithelial Autograft for Pterygium

Role: lead

NCT03217474Not ApplicableUnknown

Femtosecond Laser-assisted Corneal Debridement for Herpes Simplex Keratitis

Role: lead

All 5 trials loaded